Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.17 - $0.38 $2,754 - $6,156
16,200 Added 11.34%
159,000 $28,000
Q3 2023

Nov 14, 2023

SELL
$0.31 - $1.78 $558 - $3,204
-1,800 Reduced 1.24%
142,800 $47,000
Q2 2023

Aug 14, 2023

BUY
$1.34 - $2.08 $1,072 - $1,664
800 Added 0.56%
144,600 $211,000
Q1 2023

May 15, 2023

BUY
$1.74 - $2.54 $2,958 - $4,318
1,700 Added 1.2%
143,800 $293,000
Q4 2022

Feb 14, 2023

SELL
$2.0 - $138.16 $9,600 - $663,168
-4,800 Reduced 3.27%
142,100 $329,000
Q3 2022

Nov 14, 2022

BUY
$3.12 - $142.56 $1,872 - $85,536
600 Added 0.41%
146,900 $447,000
Q2 2022

Aug 15, 2022

SELL
$3.26 - $6.3 $5,542 - $10,710
-1,700 Reduced 1.15%
146,300 $524,000
Q1 2022

May 16, 2022

SELL
$4.48 - $8.42 $38,976 - $73,254
-8,700 Reduced 5.55%
148,000 $869,000
Q4 2021

Feb 14, 2022

BUY
$6.48 - $17.49 $1.02 Million - $2.74 Million
156,700 New
156,700 $1.23 Million
Q2 2021

Aug 16, 2021

SELL
$21.85 - $30.0 $211,945 - $291,000
-9,700 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$27.86 - $40.59 $39,004 - $56,826
-1,400 Reduced 12.61%
9,700 $296,000
Q4 2020

Feb 16, 2021

BUY
$6.21 - $48.36 $68,931 - $536,796
11,100 New
11,100 $407,000

About Aptevo Therapeutics Inc.


  • Ticker APVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,090,640
  • Market Cap $22.4M
  • Description
  • Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...
More about APVO
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.